Amgen Inc (XTER:AMG)
€ 265.4 15.2 (6.08%) Market Cap: 143.51 Bil Enterprise Value: 192.49 Bil PE Ratio: 35.86 PB Ratio: 20.00 GF Score: 88/100

Amgen Inc at Bank of America Merrill Lynch Global Healthcare Conference Transcript

Sep 15, 2022 / 08:55AM GMT
Release Date Price: €227.7 (-0.07%)
Geoffrey Christopher Meacham
BofA Securities, Research Division - Research Analyst

Excellent. Welcome to the BofA London Healthcare Conference. So my name is Geoff Meacham I'm a senior biopharma analyst here at BofA. And we're thrilled to have Amgen with us and up here on stage is Peter Griffith, CFO; and Arvind Sood, Senior Director of Investor Relations. So guys, welcome to the conference. Looking forward to the discussion.

Peter H. Griffith
Amgen Inc. - Executive VP & CFO

Geoff, thank you. Thanks for inviting us. We're glad to be here. Thank you, Bank of America. And I'd just like to open up with a few thoughts.

Geoffrey Christopher Meacham
BofA Securities, Research Division - Research Analyst

Yes, let's do that.

Peter H. Griffith
Amgen Inc. - Executive VP & CFO

First maybe share with the group. Recall our focus on long-term growth and our sharing with the group back in February about our guidance through 2030, mid-single-digit growth, upper single-digit,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot